TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/24 18:05 | 3/5/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | M.d | 287 | 22.25 | 0 | 13 | 14 | 107 | D | |||||||||||||||
3/7/24 18:05 | 3/5/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | S.d | -365 | 28.36 | 0 | -13 | -11 | 107 | D | |||||||||||||||
1/4/24 16:23 | 1/3/24 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | S.d | -300 | 17.39 | 0 | -17 | -14 | 107 | D | |||||||||||||||
1/5/23 16:06 | 1/3/23 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | S.d | -70 | 22.17 | 0 | -3 | -3 | 103 | D | |||||||||||||||
1/4/22 21:05 | 1/3/22 | RGNX | Regenxbio Inc. | Health | BioPrd | Biological Products, (No Diag | Pakola Steve | MD | O | Chief Me | S.d | -54 | 33.75 | 0 | -2 | -9 | 17 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |